Improving Lives Through Nuclear Medicine™

MTOS 2021

MTOS 2021

Jubilant Radiopharma is a proud sponsor of the

4th Annual Miami Thyroid Oncology Virtual Symposium

This two-day program will bring together experts in Endocrinology, Nuclear Medicine, Surgery, Genomics and Pathology from the U.S. and Europe. The presenters will discuss advances in Thyroid cancer genomics, diagnosis and treatment. The program is accredited by Dade County Medical Association (DCMA) for a maximum of 16 AMA PRA Category 1 credit(s).

As a leader in the field of Radioiodine Thyroid Cancer Therapy, Jubilant Radiopharma supports, through an unrestricted grant, the participation of its customers in this comprehensive educational program.

Complete the form below to receive your complimentary access code to attend the two-day course on April 9 and 10, 2021.

mtos

11 different presenters. More than 20 sessions.
Day 1: Advances in Radioiodine Theranostics
Day 2: Frontiers in Thyroid Oncology
Credits: Maximum of 16 AMA PRA Category 1 credit(s).

 

Space is limited so register today!

We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness
of campaigns and analyze traffic. If you continue to use this site we will assume your acceptance.